Latest Ratios: P/E Ratio -163.6x · EV/EBITDA 141.2x · ROE -28.2%. (2007–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.5B | $1.5B | $1.7B | $1.9B | $2.7B | $6.0B | $2.8B | $1.5B | $1.2B | $1.8B | $1.5B |
| Enterprise Value | $4.5B | $1.6B | $1.7B | $1.9B | $2.7B | $6.2B | $3.0B | $1.6B | $1.4B | $2.0B | $1.4B |
| P/E Ratio → | -163.61 | — | — | — | 21.90 | 142.25 | — | — | — | — | 23.96 |
| P/S Ratio | 6.75 | 3.23 | 4.59 | 2.77 | 2.45 | 6.73 | 5.84 | 4.75 | 3.13 | 4.16 | 3.80 |
| P/B Ratio | 9.42 | 3.34 | 3.20 | 2.80 | 4.06 | 12.28 | 7.14 | 3.63 | 3.01 | 4.52 | 4.18 |
| P/FCF | — | 214.96 | — | 165.50 | 7.90 | 46.55 | 45.71 | 21.08 | 12.71 | 25.89 | 13.55 |
| P/OCF | 227.35 | 76.93 | — | 76.60 | 7.06 | 35.71 | 37.95 | 19.23 | 11.74 | 23.32 | 12.57 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.41 | 4.67 | 2.72 | 2.42 | 6.97 | 6.34 | 5.15 | 3.62 | 4.82 | 3.59 |
| EV / EBITDA | 141.16 | — | — | 40.48 | 10.54 | 40.93 | — | 36.41 | 21.11 | 30.40 | 13.89 |
| EV / EBIT | — | — | — | — | 14.74 | 102.13 | — | — | — | — | 21.82 |
| EV / FCF | — | 226.80 | — | 162.87 | 7.81 | 48.16 | 49.69 | 22.88 | 14.68 | 29.95 | 12.79 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.8% | 56.8% | 53.4% | 55.2% | 56.9% | 52.9% | 39.5% | 45.6% | 45.9% | 42.5% | 59.3% |
| Operating Margin | -27.1% | -27.1% | -46.8% | -2.3% | 16.5% | 7.6% | -17.3% | -6.1% | -3.4% | -0.0% | 19.0% |
| Net Profit Margin | -29.2% | -29.2% | -68.0% | -10.6% | 11.2% | 4.7% | -20.6% | -6.3% | -6.8% | -2.2% | 15.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -28.2% | -28.2% | -40.8% | -10.7% | 21.5% | 9.5% | -24.5% | -4.9% | -6.7% | -2.5% | 19.9% |
| ROA | -16.4% | -16.4% | -25.1% | -6.4% | 11.2% | 4.0% | -11.2% | -2.7% | -3.2% | -1.4% | 16.2% |
| ROIC | -17.6% | -17.6% | -21.1% | -1.8% | 20.7% | 7.6% | -10.6% | -2.6% | -1.6% | -0.0% | 23.7% |
| ROCE | -19.6% | -19.6% | -21.8% | -1.9% | 21.9% | 8.2% | -11.4% | -2.9% | -1.8% | -0.0% | 22.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.35 | 0.35 | 0.29 | 0.23 | 0.23 | 0.69 | 1.00 | 0.53 | 0.65 | 0.90 | — |
| Debt / EBITDA | — | — | — | 3.38 | 0.60 | 2.24 | — | 4.92 | 3.96 | 5.22 | — |
| Net Debt / Equity | — | 0.18 | 0.06 | -0.04 | -0.05 | 0.43 | 0.62 | 0.31 | 0.47 | 0.71 | -0.24 |
| Net Debt / EBITDA | — | — | — | -0.66 | -0.13 | 1.38 | — | 2.85 | 2.84 | 4.12 | -0.83 |
| Debt / FCF | — | 11.84 | — | -2.64 | -0.09 | 1.62 | 3.99 | 1.79 | 1.97 | 4.06 | -0.76 |
| Interest Coverage | -10.18 | -10.18 | -20.95 | -4.96 | 18.83 | 4.68 | -7.87 | -1.92 | -1.30 | -2.28 | 613.40 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.34 | 1.34 | 1.77 | 2.20 | 1.65 | 1.95 | 1.55 | 2.73 | 2.56 | 2.64 | 3.92 |
| Quick Ratio | 0.92 | 0.92 | 1.28 | 1.75 | 1.18 | 1.31 | 1.13 | 2.26 | 1.97 | 1.94 | 3.44 |
| Cash Ratio | 0.40 | 0.40 | 0.66 | 0.85 | 0.61 | 0.63 | 0.64 | 1.40 | 1.05 | 0.96 | 2.40 |
| Asset Turnover | — | 0.59 | 0.42 | 0.64 | 0.94 | 0.85 | 0.46 | 0.44 | 0.50 | 0.49 | 0.92 |
| Inventory Turnover | 2.58 | 2.58 | 1.86 | 3.11 | 3.01 | 3.19 | 2.96 | 5.48 | 4.99 | 4.52 | 5.94 |
| Days Sales Outstanding | — | 36.00 | 86.52 | 89.83 | 55.71 | 48.97 | 51.43 | 58.01 | 56.40 | 57.40 | 47.51 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 4.6% | 0.7% | — | — | — | — | 4.2% |
| FCF Yield | — | 0.5% | — | 0.6% | 12.7% | 2.1% | 2.2% | 4.7% | 7.9% | 3.9% | 7.4% |
| Buyback Yield | 0.4% | 1.3% | 0.0% | 0.0% | 1.1% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.4% | 1.3% | 0.0% | 0.0% | 1.1% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $87M | $84M | $81M | $81M | $80M | $73M | $71M | $68M | $66M | $68M |
Includes 30+ ratios · 19 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MXL stock.
MaxLinear, Inc.'s current P/E ratio is -163.6x. The historical average is 56.0x.
MaxLinear, Inc.'s current EV/EBITDA is 141.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 29.7x.
MaxLinear, Inc.'s return on equity (ROE) is -28.2%. The historical average is -6.3%.
Based on historical data, MaxLinear, Inc. is trading at a P/E of -163.6x. Compare with industry peers and growth rates for a complete picture.
MaxLinear, Inc. has 56.8% gross margin and -27.1% operating margin.
Key Metrics
Top Statement Risk
Goodwill concentration and volatile conversion
Metrics are mathematically derived from official filings.
Returns Cross Zero But Remain Thin
ROIC has swung from -5.3% in 2025Q1 to +3.8% in 2026Q3, while ROE recovered to 5.7%; per MaxLinear's reported ratio series, the inflection is real but both figures remain far below typical mid-cycle fabless semiconductor returns of 15-25%.
The return trajectory is being driven almost entirely by margin recovery against a largely fixed R&D base rather than capital efficiency; asset turnover, though improved to 0.25, is still less than a third of where it sat pre-downturn, implying the ROIC rebound has further to run only if revenue keeps compounding. Notably, roughly 60% of the equity base sits in unimpaired goodwill from Exar and Intel's Home Gateway unit, so reported ROE may overstate returns on genuinely productive capital; investors should treat the current 3.8% ROIC as a cyclical floor rather than a steady-state level.
Mix-Led Margin Recovery Meets SBC Drag
Operating margin has recovered from -47.7% in 2024Q3 to +13.9% in 2026Q3 alongside a 510bp gross margin expansion to 58.7%; as disclosed in recent quarterly filings, stock-based compensation of $19.8M equals roughly two-thirds of that operating profit, materially diluting per-share quality.
The gross margin trend appears consistent with a genuine mix shift toward Infrastructure and optical DSP content rather than broad pricing power, which is the more durable interpretation given competitive pressure from Broadcom and Marvell. However, the thin 13.9% operating margin cushion beneath a ~$97M combined R&D and SG&A load means any demand wobble — particularly in the DOCSIS 4.0 cycle that remains in an uncertain early stage — could compress profitability quickly. Net margin at 13.3% should be read with caution, as the swing in 2026Q1 (-32.9%) suggests non-recurring items still distort the trailing picture.
Cycle Tightens as Inventory Lags Recovery
MaxLinear's cash conversion cycle has compressed from 236 days in 2024Q2 to 99 days in 2026Q3, driven mainly by DSO falling from 104 to 26 days; based on the company's reported working capital metrics, days in inventory at 112 remains the dominant drag on the cycle.
The DSO collapse is arguably the most encouraging operational signal in the series, as it implies distributors are drawing down rather than building — consistent with the channel-inventory headwind narrative resolving. Yet the DIO floor near 112 days, down only modestly from 233 at the trough, suggests either strategic stock ahead of the DOCSIS 4.0 ramp or slower-moving legacy Wi-Fi generations; the distinction matters because obsolescence risk in prior-generation chipsets could force valuation adjustments. The $68.8M working capital outflow in 2026Q3, which swamped positive net income, underscores how volatile this line remains and warrants close modeling of quarterly cash conversion.
Coverage Rebounds Even as Debt Creeps
Interest coverage has swung from -18.57x in 2025Q1 to +11.46x in 2026Q3, while total debt rose 33.5% to $186.0M, lifting D/E from 0.29 to 0.35; as reported in MaxLinear's recent filings, D/EBITDA of 4.76x remains the key watch metric into the next cycle.
On the surface, debt service appears comfortable — 11.46x coverage at a modest absolute debt load is not a covenant risk story in isolation. The interpretive question is why borrowing rose 33.5% in the same quarter as a $68.8M working capital outflow and a cash balance down 56% over two years; this may indicate the balance sheet is funding receivable and inventory build rather than discretionary expansion. Given negative retained earnings of -$514.9M, further debt-funded working capital swings could raise refinancing sensitivity if the broadband cycle turns before optical revenue scales.
Recovery Priced at Full Cycle Premium
MaxLinear trades at 12.31x TTM sales and 36.27x forward earnings against a TTM P/E of -40.16; as compiled from current market data, the 819.74x P/FCF and 12.16x price-to-book multiples indicate the market is paying in advance for margin recovery that has not yet been demonstrated across a full cycle.
The forward P/E of 36.27x prices MaxLinear at a premium to steady-state fabless peers, which implies consensus expects operating margins well above the 13.9% currently posted to be sustained — an assumption sensitive to both the DOCSIS 4.0 timing and competitive intensity in 400G/800G optical. P/S of 12.31x looks demanding against the peer set (Silicon Labs, MACOM, Lumentum all carry depressed or distorted earnings), but the multiple is only defensible if the 145% YoY data center infrastructure growth persists as a structural mix shift rather than a one-period catch-up. The 12.16x P/B warrants particular skepticism given that nearly 60% of the book value is unimpaired goodwill.
The P/E Trap in Cyclical Semis
The forward P/E of 36.27x is the ratio most likely to mislead investors on MaxLinear's business model, since it capitalizes a single recovery quarter's earnings while the TTM figure of -40.16x is uninterpretable; based on the reported series, mid-cycle normalized EV/EBITDA or EV/sales provide a cleaner lens.
For a fabless semiconductor company whose operating margin has swung between -47.7% and +13.9% within ten quarters, any single-period P/E — forward or trailing — is structurally unreliable because it embeds an unstated assumption about where in the cycle earnings are being measured. A normalized approach, using mid-cycle gross margins (historically 53-59%) and modeling R&D as a percentage of a mid-cycle revenue base, would reveal that MaxLinear's economic value depends far more on sustained optical mix than on the current quarter's EPS print. Investors should also discount the book-value lens, given the goodwill concentration discussed earlier, and instead anchor valuation to EV/revenue trajectories versus Semtech and Credo on the optical comparable set, where the growth-adjusted picture is more informative than any earnings multiple.